Oxford Immunotec Global financials at a glance
| Year | Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2011 | 2012 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$38.78M | $49.51M | $62.78M | $46.99M | $54.73M | $59.75M | $73.71M | $0.00M | $0.00M | $12.64M | $20.69M | $0.00M |
| GM % | Gross Margin % |
|
52.04% | 51.50% | 52.94% | 64.90% | 66.25% | 71.84% | 73.83% | 0.00% | 0.00% | 33.42% | 39.94% | 0.00% |
| OM | Operating Margin |
|
-18.95% | -43.65% | -37.52% | -50.05% | -52.79% | -29.53% | -6.80% | 0.00% | 0.00% | -105.40% | -62.51% | 0.00% |
| EPS | Earnings Per Share |
|
$0.00 | $0.00 | ||||||||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
16.43m | 17.61m | 22.54m | 22.61m | 25.65m | 26.36m | 26.45m | 25.96m | 25.58m | 0m | 0m | 0m |
| OCF | Operating Cash Flow |
|
$-5.62M | $-20.78M | $-16.55M | $-21.91M | $-3.57M | $-17.39M | $-7.16M | $0.00M | $0.00M | $-12.66M | $-14.37M | $0.00M |
| FCF | Free Cash Flow |
|
$-7.43M | $-23.79M | $-19.97M | $-24.30M | $-8.62M | $-37.47M | $-8.82M | $0.00M | $0.00M | $-13.90M | $-15.85M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-1.99 | $-1.39 | $-0.92 | $-1.02 | $-0.20 | $-0.88 | $-0.33 | $0.00 | $0.00 | $-11.43 | $-9.03 | $0.00 |